Rankings
▼
Calendar
IART Q3 2016 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$749M
Q3 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$250M
Gross Profit
$161M
64.3% margin
Operating Income
$30M
12.0% margin
Net Income
$20M
8.0% margin
EPS (Diluted)
$0.25
QoQ Revenue Growth
+0.4%
Cash Flow
Operating Cash Flow
$47M
Free Cash Flow
$40M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$1.0B
Stockholders' Equity
$823M
Cash & Equivalents
$108M
Revenue Segments
Specialty Surgical Solutions
$159M
64%
Orthopedics and Tissue Technologies
$91M
36%
Geographic Segments
UNITED STATES
$194M
78%
Europe
$29M
11%
Rest Of World
$27M
11%
← FY 2016
All Quarters
Q4 2016 →
